An observational study in Smoking Cessation and Metabolic Syndrome, sponsored by Hebrew University of Jerusalem. Completed. Open to participants aged 25 Years to 70 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2018-02-26.
Sponsored by Hebrew University of Jerusalem · Observational
Investigating the short term smoking cessation on metabolism, examining of participant of smoking cessation workshops and former participants' file survey for metabolic aspects
Objective: To examine metabolic aspects occurring during the first 6-12 months following smoking cessation in participants of smoking cessation workshops.
Design: A two armed study: prospective and retrospective. Prospective: Weight, BMI, waist circumference and waist: hip ratio were measured before, during and 6 months post cessation program. Retrospective: Blood test data for Blood fasting glucose (BFG) and lipid profile from the year preceding the workshops and the year after them were analyzed from participants' files. Smoking status was verified by phone conversation.
Volunteers who were recruited from the smoking cessation workshops of the Meuhedet HMO (Israeli Health Services) during 2016-2017.
Exclusion Criteria:
Smoking cessation workshops
Behavioral: Smoking cessation workshops
File review of former workshop participants
Behavioral: Smoking cessation workshops
All the participants took part in smoking cessation workshops. The comparison of metabolic aspects was made between the smokers and non-smokers
Change in weight
Weight in meters
Time frame: 6 months from baseline
Change in BMI
BMI in kg/m2
Time frame: 6 months from baseline
Change in waist and hip circumference
Waist and hip curcumference in centimeters
Time frame: 6 months from baseline
Change in Blood fasting glucose according to patient files (unspecified time points up to a year before and a year after the workshops)
BFG in mg/dl
Time frame: up to 2 years from baseline
Change in lipid profile according to patient files (unspecified time points up to a year before and a year after the workshops)
Lipid particle measurements in mg/dl
Time frame: up to 2 years from baseline
No study locations are listed for this record.
Documents are hosted by the registry — open the source record to download them.
Plan to share: No — This was not a part of Helsinki Committee approval. Anonymization of data for sharing is not expected.
This study is completed, as verified in Feb 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hebrew University of Jerusalem